
收稿日期: 2025-06-17
录用日期: 2025-11-27
网络出版日期: 2026-04-28
基金资助
国家自然科学基金(21906122);安徽省高校自然科学研究项目(2024AH051899);皖南医学院国家级大学生创新训练计划项目(202310368008);肿瘤免疫病理学教育部重点实验室开放课题(2024jsz1010)
Effects of triclosan exposure on the invasion ability of triple-negative breast cancer cells
Received date: 2025-06-17
Accepted date: 2025-11-27
Online published: 2026-04-28
Supported by
National Natural Science Foundation of China(21906122);Natural Science Research Project of Anhui Educational Committee(2024AH051899);National Innovation and Entrepreneurship Training Program for Undergraduates of Wannan Medical College(202310368008);Open Project of Key Laboratory of Tumor Immunology and Pathology, Ministry of Education(2024jsz1010)
目的·探究三氯生(triclosan,TCS)暴露对三阴性乳腺癌(triple-negative breast cancer,TNBC)进展的影响及其可能的作用机制。方法·采用细胞计数试剂盒8(cell counting kit-8,CCK-8)检测TCS对TNBC细胞MDA-MB-231的半数抑制浓度,以筛选TCS的暴露浓度。分别采用划痕实验、Transwell细胞侵袭实验检测TCS对MDA-MB-231细胞的迁移与侵袭能力的影响。采用实时荧光定量PCR(quantitative real-time PCR,qPCR)检测TCS对MDA-MB-231细胞中miR-21表达的影响,蛋白质印迹法(Western blotting)检测TCS对MDA-MB-231细胞上皮-间质转化(epithelial-mesenchymal transition,EMT)相关蛋白[E-钙黏蛋白(E-cadherin,E-cad)、波形蛋白(vimentin)]的影响。利用免疫组织化学技术与蛋白质印迹法检测TCS暴露对miR-21/STAT3(信号转导和转录活化因子3,signal transducer and activator of transcription 3)信号通路的影响;同时,对MDA-MB-231细胞转染miR-21 mimics,检测TCS暴露对该细胞的迁移与侵袭能力的影响。结果·根据CCK-8实验结果,筛选出TCS的暴露浓度为0.001、0.01、0.1和1 μmol/L。划痕实验与Transwell细胞侵袭实验的结果均显示,0.01、0.1、1 μmol/L TCS暴露均可增强MDA-MB-231细胞的迁移、侵袭能力(均P<0.05)。qPCR的结果表明,0.01、0.1、1 μmol/L TCS暴露后miR-21在TNBC细胞的表达水平均有所下降(均P<0.05)。蛋白质印迹法的结果显示,0.1、1 μmol/L TCS均可下调上皮细胞标志物E-cad的表达,0.01、0.1、1 μmol/L TCS均可上调间叶细胞标志物vimentin的表达(均P<0.05)。免疫组织化学与蛋白质印迹法的结果显示,0.01、0.1、1 μmol/L TCS暴露均可增加STAT3的磷酸化,且呈现剂量依赖效应(均P<0.05)。转染miR-21 mimics上调miR-21的表达后,TCS促进TNBC细胞迁移与侵袭的能力均受到了抑制(均P<0.05)。结论·TCS暴露可通过miR-21/STAT3 信号轴增强TNBC细胞的迁移与侵袭,提示TCS暴露可能对TNBC的进展产生促进效应。
关键词: 三氯生; 三阴性乳腺癌; 侵袭; miRNA-21; 信号转导和转录激活因子3
童有华 , 郭思楠 , 聂宇 , 高雅宣 , 刘世艳 , 张浩浩 , 侯英豪 , 支慧 . 三氯生暴露对三阴性乳腺癌细胞侵袭能力的影响[J]. 上海交通大学学报(医学版), 2026 , 46(4) : 442 -450 . DOI: 10.3969/j.issn.1674-8115.2026.04.004
Objective ·To investigate the effect of triclosan (TCS) exposure on the progression of triple-negative breast cancer (TNBC) and to explore the underlying mechanism. Methods ·Cell counting kit-8 (CCK-8) assay was used to detect the half-maximal inhibitory concentration of TCS in the TNBC cell line MDA-MB-231 to screen the exposure concentrations of TCS. The effects of TCS on the migration and invasion abilities of MDA-MB-231 cells were detected by wound-healing assay and Transwell invasion assays, respectively. The effect of TCS on miR-21 expression in MDA-MB-231 cells was detected by quantitative real-time PCR (qPCR). The effects of TCS on the expression of epithelial-mesenchymal transition (EMT)-related proteins, including E-cadherin (E-cad) and vimentin in MDA-MB-231 cells, were detected by Western blotting. The effect of TCS exposure on the miR-21/signal transducer and activator of transcription 3 (STAT3) signaling pathway were detected by immunohistochemistry and Western blotting. Meanwhile, miR-21 mimics were transfected into MDA-MB-231 cells to examine the effects of TCS exposure on the migration and invasion of the cells. Results ·According to the CCK-8 assay, the exposure concentrations of TCS were screened to be 0.001, 0.01, 0.1, and 1 μmol/L. Wound-healing assay and Transwell invasion assay both showed that exposure to 0.01, 0.1, and 1 μmol/L TCS enhanced the migration and invasion abilities of MDA-MB-231 cells (all P<0.05). qPCR results indicated that the expression level of miR-21 in TNBC cells was decreased after exposure to 0.01, 0.1, and 1 μmol/L TCS (all P<0.05). Western blotting results revealed that 0.1 and 1 μmol/L TCS downregulated the expression of the epithelial marker E-cad, and 0.01, 0.1, and 1 μmol/L TCS upregulated the expression of the mesenchymal marker vimentin (all P<0.05). Immunohistochemistry and Western blotting results demonstrated that exposure to 0.01, 0.1, and 1 μmol/L TCS increased the phosphorylation of STAT3 in a dose-dependent manner (all P<0.05). Upregulation of miR-21 by transfection with miR-21 mimics attenuated the promoting effect of TCS on the migration and invasion of TNBC cells (both P<0.05). Conclusion ·TCS exposure enhances the migration and invasion of TNBC cells via the miR-21/STAT3 signaling axis, suggesting that TCS exposure may exert a promoting effect on the progression of TNBC.
| [1] | Fines C, McCarthy H, Buckley N. The search for a TNBC vaccine: the guardian vaccine[J]. Cancer Biol Ther, 2025, 26(1): 2472432. |
| [2] | Liu Y H, Zou Y H, Ye Y L, et al. Advances in the understanding of the pathogenesis of triple-negative breast cancer[J]. Cancer Med, 2024, 13(22): e70410. |
| [3] | Garrido-Castro A C, Lin N U, Polyak K. Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment[J]. Cancer Discov, 2019, 9(2): 176-198. |
| [4] | Koual M, Tomkiewicz C, Cano-Sancho G, et al. Environmental chemicals, breast cancer progression and drug resistance[J]. Environ Health, 2020, 19(1): 117. |
| [5] | 许秋瑾, 应光国, 夏青, 等. 洗涤剂对水环境的风险及防控对策建议[J]. 环境工程技术学报, 2019, 9(6): 775-780. |
| Xu Q J, Ying G G, Xia Q, et al. The risk of detergent to water environment and its prevention and control countermeasure suggestions[J]. Journal of Environmental Engineering Technology, 2019, 9(6): 775-780. | |
| [6] | Ma X Q, Wan Y J, Wu M Y, et al. Occurrence of benzophenones, parabens and triclosan in the Yangtze River of China, and the implications for human exposure[J]. Chemosphere, 2018, 213: 517-525. |
| [7] | Zhu Q Q, Wang M, Jia J B, et al. Occurrence, distribution, and human exposure of several endocrine-disrupting chemicals in indoor dust: a nationwide study[J]. Environ Sci Technol, 2020, 54(18): 11333-11343. |
| [8] | Rodgers K M, Udesky J O, Rudel R A, et al. Environmental chemicals and breast cancer: an updated review of epidemiological literature informed by biological mechanisms[J]. Environ Res, 2018, 160: 152-182. |
| [9] | Lee G A, Choi K C, Hwang K A. Kaempferol, a phytoestrogen, suppressed triclosan-induced epithelial-mesenchymal transition and metastatic-related behaviors of MCF-7 breast cancer cells[J]. Environ Toxicol Pharmacol, 2017, 49: 48-57. |
| [10] | Ge J Y, Zuo W J, Chen Y Y, et al. The advance of adjuvant treatment for triple-negative breast cancer[J]. Cancer Biol Med, 2021, 19(2): 187-201. |
| [11] | Meng D S, Li Y R, Chen Z, et al. Exosomes derived from antler mesenchymal stem cells promote wound healing by miR-21-5p/STAT3 axis[J]. Int J Nanomedicine, 2024, 19: 11257-11273. |
| [12] | Tse J, Pierce T, Carli A L E, et al. Onco-miR-21 promotes Stat3-dependent gastric cancer progression[J]. Cancers, 2022, 14(2): 264. |
| [13] | Yang Z L, Liang Z Y, Rao J, et al. Hypoxic-preconditioned mesenchymal stem cell-derived small extracellular vesicles promote the recovery of spinal cord injury by affecting the phenotype of astrocytes through the miR-21/JAK2/STAT3 pathway[J]. CNS Neurosci Ther, 2024, 30(3): e14428. |
| [14] | Ma C, Shi T, Qu Z, et al. CircRNA_ACAP2 suppresses EMT in head and neck squamous cell carcinoma by targeting the miR-21-5p/STAT3 signaling axis[J]. Front Oncol, 2020, 10: 583682. |
| [15] | Grimaldi A M, Salvatore M, Incoronato M. miRNA-based therapeutics in breast cancer: a systematic review[J]. Front Oncol, 2021, 11: 668464. |
| [16] | Bao S, He C P, Ku P J, et al. Effects of triclosan on the RedoximiRs/Sirtuin/Nrf2/ARE signaling pathway in mosquitofish (Gambusia affinis)[J]. Aquat Toxicol, 2021, 230: 105679. |
| [17] | Zhao C, Xie R, Qian Q, et al. Triclosan induced zebrafish immunotoxicity by targeting miR-19a and its gene socs3b to activate IL-6/STAT3 signaling pathway[J]. Sci Total Environ, 2022, 815: 152916. |
| [18] | Farasani A, Darbre P D. Long-term exposure to triclosan increases migration and invasion of human breast epithelial cells in vitro[J]. J Appl Toxicol, 2021, 41(7): 1115-1126. |
| [19] | Yi K F, Chen W Y, Zhou X, et al. Bisphenol S exposure promotes stemness of triple-negative breast cancer cells via regulating Gli1-mediated Sonic hedgehog pathway[J]. Environ Res, 2025, 264(Pt 1): 120293. |
| [20] | Lee G A, Hwang K A, Choi K C. Inhibitory effects of 3, 3'-diindolylmethane on epithelial-mesenchymal transition induced by endocrine disrupting chemicals in cellular and xenograft mouse models of breast cancer[J]. Food Chem Toxicol, 2017, 109(Pt 1): 284-295. |
| [21] | Wang N, Wei L, Huang Y X, et al. miR520c blocks EMT progression of human breast cancer cells by repressing STAT3[J]. Oncol Rep, 2017, 37(3): 1537-1544. |
| [22] | Liao P A, Chu P Y, Tan Z L, et al. STAT3 inactivation and induction of apoptosis associate with fluoxetine-inhibited epithelial-mesenchymal transition and growth of triple-negative breast cancer in vivo[J]. Anticancer Res, 2022, 42(8): 3807-3814. |
| [23] | Shi M J, Lin Z H, Ye L H, et al. Estrogen receptor-regulated SOCS3 modulation via JAK2/STAT3 pathway is involved in BPF-induced M1 polarization of macrophages[J]. Toxicology, 2020, 433/434: 152404. |
| [24] | Wu C Y, Yin K Z, Zhang Y, et al. 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin promotes proliferation of astrocyte cells via the Akt/STAT3/Cyclin D1 pathway[J]. Biomed Environ Sci, 2019, 32(4): 281-290. |
| [25] | Wang Z Y, Wang J, Fu Q, et al. Efficient evaluation of osteotoxicity and mechanisms of endocrine disrupting chemicals using network toxicology and molecular docking approaches: triclosan as a model compound[J]. Ecotoxicol Environ Saf, 2025, 293: 118030. |
| [26] | Zhang X N, Sai B Q, Wang F, et al. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT[J]. Mol Cancer, 2019, 18(1): 40. |
| [27] | Diao W Q, Qian Q H, Sheng G Y, et al. Triclosan targets miR-144 abnormal expression to induce neurodevelopmental toxicity mediated by activating PKC/MAPK signaling pathway[J]. J Hazard Mater, 2022, 431: 128560. |
| [28] | Yang Y, Ni D Y, Wang L, et al. Triclosan has a strong influence on the development of mouse preimplantation embryo via activating miR-134/Nanog axis[J]. Toxicology, 2022, 481: 153349. |
| [29] | Wang X Y, Ren T, Zhang X N, et al. miR-21 suppression in macrophages promotes M2-like polarization and attenuates kidney ischemia-reperfusion injury[J]. FASEB J, 2024, 38(23): e70251. |
/
| 〈 |
|
〉 |